Related Experiment Video
Updated: Mar 22, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Outcomes in children with Clostridium difficile infection: results from a nationwide survey
Arjun Gupta1,2, Darrell S Pardi3, Larry M Baddour1
1Divisions of Infectious Diseases, Mayo Clinic, Rochester, MN, USA.
Insights
Clostridium difficile infection (CDI) significantly impacts hospitalized children, leading to longer hospital stays, increased colectomy rates, higher mortality, and more frequent discharge to care facilities. These adverse outcomes highlight the persistent challenge of CDI in pediatric populations.
Area of Science:
- Pediatric infectious diseases
- Hospital epidemiology
- Public health surveillance
Background:
- Clostridium difficile infection (CDI) incidence is rising in both adults and children.
- Outcomes for pediatric CDI cases are not well understood.
- Hospitalized children represent a vulnerable population for CDI.
Purpose of the Study:
- To analyze the incidence and outcomes of CDI in hospitalized children using national data.
- To identify associations between CDI and key adverse health outcomes in pediatric patients.
- To understand the impact of CDI on length of stay, colectomy, mortality, and discharge disposition.
Main Methods:
- Utilized United States National Hospital Discharge Survey (NHDS) data from 2005-2009.
- Identified CDI cases and comorbidities using ICD-9 codes.
- Performed weighted univariate and multivariate analyses to assess incidence and outcomes.
Main Results:
- An estimated 46,176 pediatric patients had CDI, with an overall incidence of 33.5 per 10,000 hospitalizations.
- CDI was independently associated with significantly increased length of stay (6.4 days), colectomy (OR 2.1), mortality (OR 2.3), and discharge to a care facility (OR 1.7).
- These associations remained significant even after adjusting for age, sex, and comorbidities.
Conclusions:
- CDI is a significant issue in hospitalized children, despite increased awareness and improved management.
- Pediatric CDI is strongly linked to adverse outcomes including prolonged hospitalization, surgical intervention (colectomy), in-hospital death, and need for post-discharge care.
- Further research and preventative strategies are warranted to mitigate the impact of CDI in pediatric patients.
Objective:
Hospital- and population-based studies demonstrate an increasing incidence of Clostridium difficile infection (CDI) in adults and children; although pediatric CDI outcomes are incompletely understood. We analysed United States National Hospital Discharge Survey (NHDS) data to study CDI in hospitalized children.
Methods:
NHDS data for 2005-2009 (demographics, diagnoses and discharge status) were obtained; cases and comorbidities were identified using ICD-9 codes. Weighted univariate and multivariate analyses were performed to ascertain incidence of CDI; associations between CDI and outcomes [length of stay (LOS), colectomy, all-cause in-hospital mortality and discharge to a care facility (DTCF)].
Results:
Of an estimated 13.8 million pediatric inpatients; 46 176 had CDI; median age was 3 years; overall incidence was 33.5/10 000 hospitalizations. The annual frequency of CDI did not vary from 2005 to 2009 (0.24-0.43%; P = 0.64). On univariate analyses, children with CDI had a longer median LOS (6 vs 2 days), higher rates of colectomy [odds ratio (OR) 2.0; 95% confidence interval (CI) 1.7-2.4], mortality (OR 2.5; 95% CI 2.3-2.7), and DTCF (OR 1.6; 95% CI 1.6-1.7) (all P < 0.0001). After adjusting for age, sex and comorbidities, CDI was an independent and the strongest predictor of increased LOS (adjusted mean difference, 6.4 days; 95% CI 5.4-7.4), higher rates of colectomy (OR 2.1; 95% CI 1.8-2.5), mortality (OR 2.3; 95% CI 2.2-2.5), and DTCF (OR 1.7; 95% CI 1.6-1.8) (all P < 0.0001). On excluding infants from the analysis, children with CDI had higher rates of mortality, DTCF and longer LOS than children without CDI.
Conclusions:
Despite increased awareness and advancements in management, CDI remains a significant problem and is associated with increased LOS, colectomy, in-hospital mortality and DTCF in hospitalized children.
Related Concept Videos
Development of Human Microbiota
Bacterial Gastroenteritis
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

